Wednesday, June 17, 2026

HomeBusiness NewsImmutep (ASX:IMM) share price slips amid trial safety update

Immutep (ASX:IMM) share price slips amid trial safety update

- Advertisement -


Image source: Getty Images

The Immutep Ltd (ASX: IMM) share price is in the red this morning, down 1.05% at the time of writing to 47 cents.

The biotech company is developing LAG-3 related immunotherapy treatments for patients with cancer and autoimmune disease.

Below, we…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed